Showing results (121-130 of 211) with videos related to

Sort By:
Pageof 22
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|December 15, 2010
[Case of thymic carcinoid associated with multiple endocrine neoplasia type I treated effectively with chemotherapy]Hiroyuki Amano, Takayuki Yamada, Takayuki Jujoh, et al.
Cellular Immunology|April 6, 2012
Expression of a murine homolog of apoptosis-inducing human IL-24/MDA-7 in murine tumors fails to induce apoptosis or produce anti-tumor effectsHiroyasu Nagakawa, Osamu Shimozato, Ling Yu, et al.
International Journal of Oncology|March 5, 2015
Interleukin-1 receptor antagonist (IL1RN) is associated with suppression of early carcinogenic events in human oral malignanciesMasashi Shiiba, Kengo Saito, Hitomi Yamagami, et al.
International Journal of Cardiology|March 17, 2011
Characterization of myofibroblasts in chronic thromboembolic pulmonary hypertensionMiki Maruoka, Seiichiro Sakao, Masashi Kantake, et al.
Experimental Lung Research|July 5, 2008
Murine pulmonary response to chronic hypoxia is strain specificYuji Tada, Sven Laudi, Julie Harral, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 24, 2016
Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trialKoichi Takayama, Nobuyuki Katakami, Takuma Yokoyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 15, 2007
[A case of angiosarcoma of pelvis with pulmonary metastases which responded to paclitaxel]Yuji Tada, Yuichi Takiguchi, Jiro Terada, et al.
Respiration; International Review of Thoracic Diseases|August 30, 2008
Tiotropium bromide attenuates respiratory syncytial virus replication in epithelial cellsKen Iesato, Koichiro Tatsumi, Kengo Saito, et al.
Cancer|May 2, 2006
Sequential gene expression changes in cancer cell lines after treatment with the demethylation agent 5-Aza-2'-deoxycytidineMakoto Arai, Osamu Yokosuka, Yuichi Hirasawa, et al.
Plos One|April 5, 2013
Zoledronic acid produces combinatory anti-tumor effects with cisplatin on mesothelioma by increasing p53 expression levelsShinya Okamoto, Yuanyuan Jiang, Kiyoko Kawamura, et al.
Pageof 22